Watch Demo

IVF Services Market by Cycle Type, and End User - Global Opportunity Analysis and Industry Forecast, 2018-2025

IVF Services Market by Cycle Type, and End User - Global Opportunity Analysis and Industry Forecast, 2018-2025

  • Publish Date:July 2018

  • Number of Pages:606

  • Report ID:5563968

  • Format:PDF

  • Publisher:Allied Market Research

$ 4650

Summary

IVF Services Market by Cycle Type (Fresh IVF Cycles (Non-Donor), Thawed IVF Cycles (Non-Donor), and Donor Egg IVF Cycles), and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes) - Global Opportunity Analysis and Industry Forecast, 2018-2025

In vitro fertilization is an assisted reproductive technology (ART), which involves retrieving eggs from a woman’s ovaries and fertilizing them with sperm outside the body, in vitro. The global IVF services revenue market generated $10,587 million in 2017 and is projected to reach $22,467 million by 2025, growing at a CAGR of 9.8% from 2018 to 2025.

The global IVF services market is anticipated to exhibit significant market growth during the forecast period, owing to rise in infertility rate, increase in trend of delayed pregnancies, surge in IVF success rate, and rise in disposable income worldwide. However, high cost, complications associated with IVF treatment, and low awareness level for IVF in some under developed regions hinder the growth of the market. Conversely, upsurge in fertility tourism, increase in number of fertility clinics, and growth opportunities in the emerging markets make way for market development in the future.

The global IVF services market is segmented based on cycle type, end user, and region. Based on cycle type, the market is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. According to end user, the market is classified as fertility clinics, hospitals, surgical centers and clinical research institutes. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia, Denmark, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, Thailand, New Zealand, South Korea and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa).

KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
Key players are profiled to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Cycle Type
Fresh IVF Cycles (Non-Donor)
Thawed IVF Cycles (Non-Donor)
Donor Egg IVF Cycles

By End User
Fertility Clinics
Hospitals
Surgical centers
Clinical research institutes

By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Denmark
Russia
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
New Zealand
Thailand
Rest of Asia-Pacific
LAMEA
Latin America
Middle East
Africa

LIST OF KEY PLAYERS PROFILED IN THE REPORT
Ambroise Paré Group
amedes MVZ Cologne GmbH
AMP Center St Roch
AVA Clinic Scanfert
Bangkok IVF center
Bangkok IVF center (Bangkok Hospital)
Betamedics
Biofertility Center
Bloom Fertility and Healthcare
Bloom Fertility Center
Bourn Hall Fertility Center
Bourn Hall International
Cardone Reproductive Medicine and Infertility, LLC
Center for Advanced Reproductive Medicine and Infertility
CHA Fertility Center
Chelsea and Westminster Hospital (Assisted Conception Unit)
Cloudnine Fertility
Conceptions Reproductive Associates of Colorado
Cyprus IVF Centre
Dansk Fertilitetsklinik
EUVITRO S.L.U.
Fakih IVF Fertility Center
Fertility and Gynecology Center Monterey Bay IVF
Fertility Associates
Fertility Center Berlin
Fertility Center of San Antoni
Fertility First
FIV Marbella
Fivet Centers Prof. Zech
Flinders Reproductive Medicine Pty Ltd
Genea Oxford Fertility Limited
Heidelberg University Hospital
Houston Fertility Center
International Centre for Reproductive Medicine, ICRM
IVF Canada
IVF NAMBA Clinic
IVF Panama Center for Reproduction Punta Pacífica
IVF Spain
IVI Panama
Ivinsemer
KL Fertility & Gynaecology Centre
Lifesure Fertility and Gynaecology centre
LIV Fertility Center
Manipal Fertility
Maria Fertility Hospital
MD Medical Group
Medfem Fertility Clinic
Monash IVF Wesley Hospital Auchenflower
Morpheus Life Sciences Pvt. Ltd.
New hope fertility center
Oak Medical Group/Oak Clinic
OVA IVF Clinic Zurich
Procrea Fertility
RAPRUI Srl
Repromed
SAFE Fertility Center
Sanno Hospital
Servy Massey Fertility Institute
Shanghai Ji Ai Genetics & IVF Institute
Shanghai United Family Hospital
Sher Institute for Reproductive Medicine (SIRM)
Southend Fertility and IVF
StorkKlinik (Stork IVF Clinic)
The ARC-STER Center
The Bridge Centre
The Cape Fertility Clinic
The Hugh Wynter Fertility Management Unit
The Lister Fertility Clinic
The Montreal Fertility Center
Thomson Medical Pte. Ltd.
Trianglen Fertility Clinic
TRIO Fertility
Virtus Health
Vitanova
VivaNeo - Medical Center Kinderwens
Wunschkinder

Table of contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key Findings of the Study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. IVF Pricing Trends
3.3. IVF Cycles, By Country
3.4. Global IVF Services Market, By End User
3.4.1. Market size and forecast
3.4.2. Market volume and forecast
3.4.3. Fertility clinics
3.4.3.1. Market size and forecast
3.4.4. Hospitals
3.4.4.1. Market size and forecast
3.4.5. Surgical centers
3.4.5.1. Market size and forecast
3.4.6. Clinical research institutes
3.4.6.1. Market size and forecast
3.5. Global IVF Services Market, By Cycle Type
3.5.1. Market size and forecast
3.5.2. Market volume and forecast
3.5.3. Fresh IVF cycles (non-donor)
3.5.3.1. Market size and forecast
3.5.4. Thawed IVF cycles (non-donor)
3.5.4.1. Market size and forecast
3.5.5. Donor egg IVF cycles
3.5.5.1. Market size and forecast
3.6. Market Dynamics
3.6.1. Drivers
3.6.1.1. Delayed pregnancies in women
3.6.1.2. Increase in global infertility rates
3.6.1.3. Increase in gamete donations
3.6.1.4. Increase in disposable income
3.6.1.5. Increase in IVF success rates
3.6.1.6. Surge in healthcare expenditure worldwide
3.6.2. Restraints
3.6.2.1. Cost constraints
3.6.2.2. Complications associated with IVF treatment
3.6.2.3. Low awareness level
3.6.3. Opportunities
3.6.3.1. Fertility tourism
3.6.3.2. Growth opportunities in the emerging markets
3.6.3.3. Increase in number of fertility clinics
3.6.3.4. Rise in same sex marriage
3.6.4. Impact analyses
3.7. Key Findings

CHAPTER 4: NORTH AMERICA IVF SERVICES MARKET
4.1. Overview
4.1.1. Market size and forecast
4.1.1.1. By country
4.1.1.2. By end user
4.1.1.3. By cycle type
4.1.2. Market volume and forecast
4.1.2.1. By country
4.1.2.2. By end user
4.1.2.3. By cycle type
4.2. U.S. IVF Services Market, (Revenue and Number of Cycles)
4.2.1. Overview
4.2.2. Market size and forecast
4.2.3. IVF clinics in the U.S.
4.2.4. U.S. IVF services market, by end user
4.2.4.1. Market size and forecast
4.2.4.2. Market volume and forecast
4.2.4.3. Fertility clinics
4.2.4.4. Hospitals
4.2.4.5. Surgical centers
4.2.4.6. Clinical research institutes
4.2.5. U.S. IVF services market, by cycle type
4.2.5.1. Market size and forecast
4.2.5.2. Market volume and forecast
4.2.5.3. Fresh IVF cycles (non-donor)
4.2.5.4. Thawed IVF cycles (non-donor)
4.2.5.5. Donor egg IVF cycles
4.2.6. Market dynamics
4.2.6.1. Driving factors
4.2.6.1.1. Increasing popularity of IVF in U.S.
4.2.6.1.2. Increased rate of infertility and practices of embryo banking cycles
4.2.6.2. Restraining factors
4.2.6.2.1. High cost of IVF treatment in U.S.
4.2.6.2.2. Restrictions on 3-parent IVF treatments
4.2.6.2.3. Scattered Reimbursements
4.2.7. Regulatory issues, legislations and authorities
4.2.8. Insurance reimbursement scenario
4.2.9. Company profiles
4.2.9.1. Fertility and Gynecology Center Monterey Bay IVF
4.2.9.1.1. Company overview
4.2.9.2. Conceptions Reproductive Associates of Colorado
4.2.9.2.1. Company overview
4.2.9.3. Servy Massey Fertility Institute
4.2.9.3.1. Company overview
4.2.9.4. Sher Institute for Reproductive Medicine (SIRM)
4.2.9.4.1. Company overview
4.2.9.5. Cardone Reproductive Medicine and Infertility, LLC
4.2.9.5.1. Company overview
4.2.9.6. Fertility Center of San Antoni
4.2.9.6.1. Company overview
4.2.9.7. Houston Fertility Center
4.2.9.7.1. Company overview
4.2.9.8. New hope fertility center
4.2.9.8.1. Company overview
4.3. Canada IVF Services Market, (Revenue and Number of Cycles)
4.3.1. Overview
4.3.2. Market size and forecast
4.3.3. IVF clinics in Canada
4.3.4. Canada IVF services market, by end user
4.3.4.1. Market size and forecast
4.3.4.2. Market volume and forecast
4.3.4.3. Fertility clinics
4.3.4.4. Hospitals
4.3.4.5. Surgical centers
4.3.4.6. Clinical research institutes
4.3.5. Canada IVF services market, by cycle type
4.3.5.1. Market size and forecast
4.3.5.2. Market volume and forecast
4.3.5.3. Fresh IVF cycles (non-donor)
4.3.5.4. Thawed IVF cycles (non-donor)
4.3.5.5. Donor egg IVF cycles
4.3.6. Market dynamics
4.3.6.1. Driving factors
4.3.6.1.1. Commercialization of IVF booster in Canada
4.3.6.2. Restraining factors
4.3.6.2.1. High cost of IVF treatment in Canada
4.3.7. Regulatory issues, legislations and authorities
4.3.8. Insurance reimbursement scenario
4.3.9. Company profiles
4.3.9.1. TRIO Fertility
4.3.9.1.1. Company overview
4.3.9.2. The Montreal Fertility Center
4.3.9.2.1. Company overview
4.3.9.3. Procrea Fertility
4.3.9.3.1. Company overview
4.3.9.4. IVF Canada
4.3.9.4.1. Company overview
4.4. Mexico IVF Services Market, (Revenue and Number of Cycles)
4.4.1. Overview
4.4.2. Market size and forecast
4.4.3. IVF clinics in Mexico
4.4.4. Mexico IVF services market, by end user
4.4.4.1. Market size and forecast
4.4.4.2. Market volume and forecast
4.4.4.3. Fertility clinics
4.4.4.4. Hospitals
4.4.4.5. Surgical centers
4.4.4.6. Clinical research institutes
4.4.5. Mexico IVF services market, by cycle type
4.4.5.1. Market size and forecast
4.4.5.2. Market volume and forecast
4.4.5.3. Fresh IVF cycles (non-donor)
4.4.5.4. Thawed IVF cycles (non-donor)
4.4.5.5. Donor egg IVF cycles
4.4.6. Market dynamics
4.4.6.1. Driving factors
4.4.6.1.1. Fertility tourism
4.4.6.1.2. Comparatively low cost of IVF
4.4.6.2. Restraining factors
4.4.6.2.1. Language barriers
4.4.7. Regulatory issues, legislations and authorities
4.4.8. Insurance reimbursement scenario
4.4.9. Company profiles
4.4.9.1. LIV Fertility Center
4.4.9.1.1. Company overview
4.4.9.2. Biofertility Center
4.4.9.2.1. Company overview
4.4.9.3. Ivinsemer
4.4.9.3.1. Company overview

CHAPTER 5: EUROPE IVF SERVICES MARKET
5.1. Overview
5.1.1. Market size and forecast
5.1.1.1. By country
5.1.1.2. By end user
5.1.1.3. By cycle type
5.1.2. Market volume and forecast
5.1.2.1. By country
5.1.2.2. By end user
5.1.2.3. By cycle type
5.2. Germany IVF Services Market, (Revenue and Number of Cycles)
5.2.1. Overview
5.2.2. Market size and forecast
5.2.3. IVF clinics in Germany
5.2.4. Germany IVF services market, by end user
5.2.4.1. Market size and forecast
5.2.4.2. Market volume and forecast
5.2.4.3. Fertility clinics
5.2.4.4. Hospitals
5.2.4.5. Surgical centers
5.2.4.6. Clinical research institutes
5.2.5. Germany IVF services market, by cycle type
5.2.5.1. Market size and forecast
5.2.5.2. Market volume and forecast
5.2.5.3. Fresh IVF cycles (non-donor)
5.2.5.4. Thawed IVF cycles (non-donor)
5.2.6. Market dynamics
5.2.6.1. Driving factors
5.2.6.1.1. Subsidizing IVF treatments
5.2.6.1.2. Delayed marriages and parenthood decisions
5.2.6.2. Restraining factors
5.2.6.2.1. Limited adoption of IVF methods
5.2.7. Regulatory issues, legislations and authorities
5.2.8. Insurance reimbursement scenario
5.2.9. Company profiles
5.2.9.1. Heidelberg University Hospital
5.2.9.1.1. Company overview
5.2.9.2. Wunschkinder
5.2.9.2.1. Company overview
5.2.9.3. Fertility Center Berlin
5.2.9.3.1. Company overview
5.2.9.4. amedes MVZ Cologne GmbH
5.2.9.4.1. Company overview
5.3. France IVF Services Market, (Revenue and Number of Cycles)
5.3.1. Overview
5.3.2. Market size and forecast
5.3.3. IVF clinics in France
5.3.4. France IVF services market, by end user
5.3.4.1. Market size and forecast
5.3.4.2. Market volume and forecast
5.3.4.3. Fertility clinics
5.3.4.4. Hospitals
5.3.4.5. Surgical centers
5.3.4.6. Clinical research institutes
5.3.5. France IVF services market, by cycle type
5.3.5.1. Market size and forecast
5.3.5.2. Market volume and forecast
5.3.5.3. Fresh IVF cycles (non-donor)
5.3.5.4. Thawed IVF cycles (non-donor)
5.3.5.5. Donor egg IVF cycles
5.3.6. Market dynamics
5.3.6.1. Driving factors
5.3.6.1.1. Rising adoption of IVF babies among same gender population
5.3.6.1.2. Lower rates of Fertility
5.3.6.2. Restraining factors
5.3.6.2.1. Stringent government regulations
5.3.7. Regulatory issues, legislations and authorities
5.3.8. Insurance reimbursement scenario
5.3.9. Company profiles
5.3.9.1. Ambroise Par Group
5.3.9.1.1. Company overview
5.3.9.2. AMP Center St Roch
5.3.9.2.1. Company overview
5.4. UK IVF Services Market, (Revenue and Number of Cycles)
5.4.1. Overview
5.4.2. Market size and forecast
5.4.3. IVF clinics in UK
5.4.4. UK IVF services market, by end user
5.4.4.1. Market size and forecast
5.4.4.2. Market volume and forecast
5.4.4.3. Fertility clinics
5.4.4.4. Hospitals
5.4.4.5. Surgical centers
5.4.4.6. Clinical research institutes
5.4.5. UK IVF services market, by cycle type
5.4.5.1. Market size and forecast
5.4.5.2. Market volume and forecast
5.4.5.3. Fresh IVF cycles (non-donor)
5.4.5.4. Thawed IVF cycles (non-donor)
5.4.5.5. Donor egg IVF cycles
5.4.6. Market dynamics
5.4.6.1. Driving factors
5.4.6.1.1. Commercialization of three-parent IVF procedures
5.4.6.1.2. Supportive Regulations
5.4.6.2. Restraining factors
5.4.6.2.1. Ethical considerations
5.4.7. Regulatory issues, legislations and authorities
5.4.8. Insurance reimbursement scenario
5.4.9. Company profiles
5.4.9.1. The Lister Fertility Clinic
5.4.9.1.1. Company overview
5.4.9.2. The Bridge Centre
5.4.9.2.1. Company overview
5.4.9.3. Chelsea and Westminster Hospital (Assisted Conception Unit)
5.4.9.3.1. Company overview
5.5. Italy IVF Services Market, (Revenue and Number of Cycles)
5.5.1. Overview
5.5.2. Market size and forecast
5.5.3. Italy IVF services market, by end user
5.5.3.1. Market size and forecast
5.5.3.2. Market volume and forecast
5.5.3.3. Fertility clinics
5.5.3.4. Hospitals
5.5.3.5. Surgical centers
5.5.3.6. Clinical research institutes
5.5.4. Italy IVF services market, by cycle type
5.5.4.1. Market size and forecast
5.5.4.2. Market volume and forecast
5.5.4.3. Fresh IVF cycles (non-donor)
5.5.4.4. Thawed IVF cycles (non-donor)
5.5.4.5. Donor egg IVF cycles
5.5.5. Market dynamics
5.5.5.1. Driving factors
5.5.5.1.1. Rise in medical tourism
5.5.5.2. Restraining factors
5.5.5.2.1. Ban on surrogacy
5.5.6. Regulatory issues, legislations and authorities
5.5.7. Insurance reimbursement scenario
5.5.8. Company profiles
5.5.8.1. The ARC-STER Center
5.5.8.1.1. Company overview
5.5.8.2. RAPRUI Srl
5.5.8.2.1. Company overview
5.5.8.3. Fivet Centers Prof. Zech
5.5.8.3.1. Company overview
5.6. Spain IVF Services Market, (Revenue and Number of Cycles)
5.6.1. Overview
5.6.2. Market size and forecast
5.6.3. Spain IVF services market, by end user
5.6.3.1. Market size and forecast
5.6.3.2. Market volume and forecast
5.6.3.3. Fertility clinics
5.6.3.4. Hospitals
5.6.3.5. Surgical centers
5.6.3.6. Clinical research institutes
5.6.4. Spain IVF services market, by cycle type
5.6.4.1. Market size and forecast
5.6.4.2. Market volume and forecast
5.6.4.3. Fresh IVF cycles (non-donor)
5.6.4.4. Thawed IVF cycles (non-donor)
5.6.4.5. Donor egg IVF cycles
5.6.5. Market dynamics
5.6.5.1. Driving factors
5.6.5.1.1. Increase in the number of foreign patients
5.6.5.2. Restraining factors
5.6.5.2.1. Limited awareness and language barriers
5.6.6. Regulatory issues, legislations and authorities
5.6.7. Insurance reimbursement scenario
5.6.8. Company profiles
5.6.8.1. IVF Spain
5.6.8.1.1. Company overview
5.6.8.2. EUVITRO S.L.U.
5.6.8.2.1. Company overview
5.6.8.3. FIV Marbella
5.6.8.3.1. Company overview
5.7. Denmark IVF Services Market, (Revenue and Number of Cycles)
5.7.1. Overview
5.7.2. Market size and forecast
5.7.3. Denmark IVF services market, by end user
5.7.3.1. Market size and forecast
5.7.3.2. Market volume and forecast
5.7.3.3. Fertility clinics
5.7.3.4. Hospitals
5.7.3.5. Surgical centers
5.7.3.6. Clinical research institutes
5.7.4. Denmark IVF services market, by cycle type
5.7.4.1. Market size and forecast
5.7.4.2. Market volume and forecast
5.7.4.3. Fresh IVF cycles (non-donor)
5.7.4.4. Thawed IVF cycles (non-donor)
5.7.4.5. Donor egg IVF cycles
5.7.5. Market dynamics
5.7.5.1. Driving factors
5.7.5.1.1. Increase in disposable income
5.7.5.1.2. Advances in IVF technology
5.7.5.2. Restraining factors
5.7.5.2.1. Reimbursement in public clinics only
5.7.6. Regulatory issues, legislations and authorities
5.7.7. Insurance reimbursement scenario
5.7.8. Company profiles
5.7.8.1. Vitanova
5.7.8.1.1. Company overview
5.7.8.2. Dansk Fertilitetsklinik
5.7.8.2.1. Company overview
5.7.8.3. StorkKlinik (Stork IVF Clinic)
5.7.8.3.1. Company overview
5.7.8.4. Trianglen Fertility Clinic
5.7.8.4.1. Company overview
5.8. Russia IVF Services Market, (Revenue and Number of Cycles)
5.8.1. Overview
5.8.2. Market size and forecast
5.8.3. Russia IVF services market, by end user
5.8.3.1. Market size and forecast
5.8.3.2. Market volume and forecast
5.8.3.3. Fertility clinics
5.8.3.4. Hospitals
5.8.3.5. Surgical centers
5.8.3.6. Clinical research institutes
5.8.4. Russia IVF services market, by cycle type
5.8.4.1. Market size and forecast
5.8.4.2. Market volume and forecast
5.8.4.3. Fresh IVF cycles (non-donor)
5.8.4.4. Thawed IVF cycles (non-donor)
5.8.4.5. Donor egg IVF cycles
5.8.5. Market dynamics
5.8.5.1. Driving factors
5.8.5.1.1. Rising popularity of fertility tourism
5.8.5.2. Restraining factors
5.8.5.2.1. Language barrier
5.8.6. Regulatory issues, legislations and authorities
5.8.7. Insurance reimbursement scenario
5.8.8. Company profiles
5.8.8.1. AVA Clinic Scanfert
5.8.8.1.1. Company overview
5.8.8.2. MD Medical Group
5.8.8.2.1. Company overview
5.8.8.3. International Centre for Reproductive Medicine, ICRM
5.8.8.3.1. Company overview
5.9. Rest of Europe IVF Services Market, (Revenue and Number of Cycles)
5.9.1. Overview
5.9.2. Market size and forecast
5.9.3. Rest of Europe IVF services market, by end user
5.9.3.1. Market size and forecast
5.9.3.2. Market volume and forecast
5.9.3.3. Fertility clinics
5.9.3.4. Hospitals
5.9.3.5. Surgical centers
5.9.3.6. Clinical research institutes
5.9.4. Rest of Europe IVF services market, by cycle type
5.9.4.1. Market size and forecast
5.9.4.2. Market volume and forecast
5.9.4.3. Fresh IVF cycles (non-donor)
5.9.4.4. Thawed IVF cycles (non-donor)
5.9.4.5. Donor egg IVF cycles
5.9.5. Market dynamics
5.9.5.1. Driving factors
5.9.5.1.1. Wide availability of reimbursements
5.9.5.1.2. Changes in lifestyle
5.9.5.2. Restraining factors
5.9.6. Regulatory issues, legislations and authorities
5.9.7. Insurance reimbursement scenario
5.9.8. Company profiles
5.9.8.1. Betamedics
5.9.8.1.1. Company overview
5.9.8.2. OVA IVF Clinic Zurich
5.9.8.2.1. Company overview
5.9.8.3. VivaNeo - Medical Center Kinderwens
5.9.8.3.1. Company overview

CHAPTER 6: ASIA-PACIFIC IVF SERVICES MARKET
6.1. Overview
6.1.1. Market size and forecast
6.1.1.1. By country
6.1.1.2. By end user
6.1.1.3. By cycle type
6.1.2. Market volume and forecast
6.1.2.1. By country
6.1.2.2. By end user
6.1.2.3. By cycle type
6.2. India IVF Services Market, (Revenue and Number of Cycles)
6.2.1. Overview
6.2.2. Market size and forecast
6.2.3. IVF clinics in India
6.2.4. India IVF services market, by end user
6.2.4.1. Market size and forecast
6.2.4.2. Market volume and forecast
6.2.4.3. Fertility clinics
6.2.4.4. Hospitals
6.2.4.5. Surgical centers
6.2.4.6. Clinical research institutes
6.2.5. India IVF services market, by cycle type
6.2.5.1. Market size and forecast
6.2.5.2. Market volume and forecast
6.2.5.3. Fresh IVF cycles (non-donor)
6.2.5.4. Thawed IVF cycles (non-donor)
6.2.5.5. Donor egg IVF cycles
6.2.6. Market dynamics
6.2.6.1. Driving factors
6.2.6.2. Restraining factors
6.2.7. Regulatory issues, legislations and authorities
6.2.8. Insurance reimbursement scenario
6.2.9. Company profiles
6.2.9.1. Bourn Hall Fertility Center
6.2.9.1.1. Company overview
6.2.9.2. Southend Fertility and IVF
6.2.9.2.1. Company overview
6.2.9.3. Morpheus Life Sciences Pvt. Ltd.
6.2.9.3.1. Company overview
6.2.9.4. Bloom Fertility Center
6.2.9.4.1. Company overview
6.2.9.5. Bloom Fertility and Healthcare
6.2.9.5.1. Company overview
6.2.9.6. Manipal Fertility
6.2.9.6.1. Company overview
6.2.9.7. Cloudnine Fertility
6.2.9.7.1. Company overview
6.3. China IVF Services Market, (Revenue and Number of Cycles)
6.3.1. Overview
6.3.2. Market size and forecast
6.3.3. China IVF services market, by end user
6.3.3.1. Market size and forecast
6.3.3.2. Market volume and forecast
6.3.3.3. Fertility clinics
6.3.3.4. Hospitals
6.3.3.5. Surgical centers
6.3.3.6. Clinical research institutes
6.3.4. China IVF services market, by cycle type
6.3.4.1. Market size and forecast
6.3.4.2. Market volume and forecast
6.3.4.3. Fresh IVF cycles (non-donor)
6.3.4.4. Thawed IVF cycles (non-donor)
6.3.4.5. Donor egg IVF cycles
6.3.5. Market dynamics
6.3.5.1. Driving factors
6.3.5.2. Restraining factors
6.3.6. Regulatory issues, legislations and authorities
6.3.7. Insurance reimbursement scenario
6.3.8. Company profiles
6.3.8.1. Shanghai Ji Ai Genetics & IVF Institute
6.3.8.1.1. Company overview
6.3.8.2. Shanghai United Family Hospital
6.3.8.2.1. Company overview
6.4. Japan IVF Services Market, (Revenue and Number of Cycles)
6.4.1. Overview
6.4.2. Market size and forecast
6.4.3. Japan IVF services market, by end user
6.4.3.1. Market size and forecast
6.4.3.2. Market volume and forecast
6.4.3.3. Fertility clinics
6.4.3.4. Hospitals
6.4.3.5. Surgical centers
6.4.3.6. Clinical research institutes
6.4.4. Japan IVF services market, by cycle type
6.4.4.1. Market size and forecast
6.4.4.2. Market volume and forecast
6.4.4.3. Fresh IVF cycles (non-donor)
6.4.4.4. Thawed IVF cycles (non-donor)
6.4.4.5. Donor egg IVF cycles
6.4.5. Market dynamics
6.4.5.1. Driving factors
6.4.5.2. Restraining factors
6.4.6. Regulatory issues, legislations and authorities
6.4.7. Insurance reimbursement scenario
6.4.8. Company profiles
6.4.8.1. IVF NAMBA Clinic
6.4.8.1.1. Company overview
6.4.8.2. Sanno Hospital
6.4.8.2.1. Company overview
6.4.8.3. Oak Medical Group/Oak Clinic
6.4.8.3.1. Company overview
6.5. Australia IVF Services Market, (Revenue and Number of Cycles)
6.5.1. Overview
6.5.2. Market size and forecast
6.5.3. IVF clinics in Australia
6.5.4. Australia IVF services market, by end user
6.5.4.1. Market size and forecast
6.5.4.2. Market volume and forecast
6.5.4.3. Fertility clinics
6.5.4.4. Hospitals
6.5.4.5. Surgical centers
6.5.4.6. Clinical research institutes
6.5.5. Australia IVF services market, by cycle type
6.5.5.1. Market size and forecast
6.5.5.2. Market volume and forecast
6.5.5.3. Fresh IVF cycles (non-donor)
6.5.5.4. Thawed IVF cycles (non-donor)
6.5.5.5. Donor egg IVF cycles
6.5.6. Market dynamics
6.5.6.1. Driving factors
6.5.6.2. Restraining factors
6.5.7. Regulatory issues, legislations and authorities
6.5.8. Insurance reimbursement scenario
6.5.9. Company profiles
6.5.9.1. Virtus Health
6.5.9.1.1. Company overview
6.5.9.2. Monash IVF Wesley Hospital Auchenflower
6.5.9.2.1. Company overview
6.5.9.3. Fertility First
6.5.9.3.1. Company overview
6.5.9.4. Flinders Reproductive Medicine Pty Ltd
6.5.9.4.1. Company overview
6.6. New Zealand IVF Services Market, (Revenue and Number of Cycles)
6.6.1. Overview
6.6.2. Market size and forecast
6.6.3. New Zealand IVF services market, by end user
6.6.3.1. Market size and forecast
6.6.3.2. Market volume and forecast
6.6.3.3. Fertility clinics
6.6.3.4. Hospitals
6.6.3.5. Surgical centers
6.6.3.6. Clinical research institutes
6.6.4. New Zealand IVF services market, by cycle type
6.6.4.1. Market size and forecast
6.6.4.2. Market volume and forecast
6.6.4.3. Fresh IVF cycles (non-donor)
6.6.4.4. Thawed IVF cycles (non-donor)
6.6.4.5. Donor egg IVF cycles
6.6.5. Market dynamics
6.6.5.1. Driving factors
6.6.5.2. Restraining factors
6.6.6. Regulatory issues, legislations and authorities
6.6.7. Insurance reimbursement scenario
6.6.8. Company profiles
6.6.8.1. Fertility Associates
6.6.8.1.1. Company overview
6.6.8.2. Genea Oxford Fertility Limited
6.6.8.2.1. Company overview
6.6.8.3. Repromed
6.6.8.3.1. Company overview
6.7. South Korea IVF Services Market, (Revenue and Number of Cycles)
6.7.1. Overview
6.7.2. Market size and forecast
6.7.3. IVF clinics in South Korea
6.7.4. South Korea IVF Services Market, by end user
6.7.4.1. Market size and forecast
6.7.4.2. Market volume and forecast
6.7.4.3. Fertility clinics
6.7.4.4. Hospitals
6.7.4.5. Surgical centers
6.7.4.6. Clinical research institutes
6.7.5. South Korea IVF services market, by cycle type
6.7.5.1. Market size and forecast
6.7.5.2. Market volume and forecast
6.7.5.3. Fresh IVF cycles (non-donor)
6.7.5.4. Thawed IVF cycles (non-donor)
6.7.5.5. Donor egg IVF cycles
6.7.6. Market dynamics
6.7.6.1. Driving factors
6.7.6.2. Restraining factors
6.7.7. Regulatory issues, legislations and authorities
6.7.8. Insurance reimbursement scenario
6.7.9. Company profiles
6.7.9.1. CHA Fertility Center
6.7.9.1.1. Company overview
6.7.9.2. Maria Fertility Hospital
6.7.9.2.1. Company overview
6.8. Thailand IVF Services Market, (Revenue and Number of Cycles)
6.8.1. Overview
6.8.2. Market size and forecast
6.8.3. Thailand IVF services market, by end user
6.8.3.1. Market size and forecast
6.8.3.2. Market volume and forecast
6.8.3.3. Fertility clinics
6.8.3.4. Hospitals
6.8.3.5. Surgical centers
6.8.3.6. Clinical research institutes
6.8.4. Thailand IVF services market, by cycle type
6.8.4.1. Market size and forecast
6.8.4.2. Market volume and forecast
6.8.4.3. Fresh IVF cycles (non-donor)
6.8.4.4. Thawed IVF cycles (non-donor)
6.8.4.5. Donor egg IVF cycles
6.8.5. Market dynamics
6.8.5.1. Driving factors
6.8.5.2. Restraining factors
6.8.6. Regulatory issues, legislations and authorities
6.8.7. Insurance reimbursement scenario
6.8.8. Company profiles
6.8.8.1. SAFE Fertility Center
6.8.8.1.1. Company overview
6.8.8.2. Bangkok IVF center (Bangkok Hospital)
6.8.8.2.1. Company overview
6.8.8.3. Bangkok IVF center
6.8.8.3.1. Company overview
6.9. Rest of Asia-Pacific IVF Services Market, (Revenue and Number of Cycles)
6.9.1. Overview
6.9.2. Market size and forecast
6.9.3. Rest of Asia-Pacific IVF services market, by end user
6.9.3.1. Market size and forecast
6.9.3.2. Market volume and forecast
6.9.3.3. Fertility clinics
6.9.3.4. Hospitals
6.9.3.5. Surgical centers
6.9.3.6. Clinical research institutes
6.9.4. Rest of Asia-Pacific IVF services market, by cycle type
6.9.4.1. Market size and forecast
6.9.4.2. Market volume and forecast
6.9.4.3. Fresh IVF cycles (non-donor)
6.9.4.4. Thawed IVF cycles (non-donor)
6.9.4.5. Donor egg IVF cycles
6.9.5. Market dynamics
6.9.5.1. Driving factors
6.9.5.2. Restraining factors
6.9.6. Regulatory issues, legislations and authorities
6.9.7. Insurance reimbursement scenario
6.9.8. Company profiles
6.9.8.1. Center for Advanced Reproductive Medicine and Infertility
6.9.8.1.1. Company overview
6.9.8.2. Thomson Medical Pte. Ltd.
6.9.8.2.1. Company overview
6.9.8.3. KL Fertility & Gynaecology Centre
6.9.8.3.1. Company overview

CHAPTER 7: LAMEA IVF SERVICES MARKET
7.1. Overview
7.1.1. Market size and forecast
7.1.1.1. By country
7.1.1.2. By end user
7.1.1.3. By cycle type
7.1.2. Market volume and forecast
7.1.2.1. By country
7.1.2.2. By end user
7.1.2.3. By cycle type
7.2. Latin America IVF Services Market, (Revenue and Number of Cycles)
7.2.1. Overview
7.2.2. Market size and forecast
7.2.3. IVF clinics in Latin America
7.2.4. Latin America IVF services market, by end user
7.2.4.1. Market size and forecast
7.2.4.2. Market volume and forecast
7.2.4.3. Fertility clinics
7.2.4.4. Hospitals
7.2.4.5. Surgical centers
7.2.4.6. Clinical research institutes
7.2.5. Latin America IVF services market, by cycle type
7.2.5.1. Market size and forecast
7.2.5.2. Market volume and forecast
7.2.5.3. Fresh IVF cycles (non-donor)
7.2.5.4. Thawed IVF cycles (non-donor)
7.2.5.5. Donor egg IVF cycles
7.2.6. Market dynamics
7.2.6.1. Driving factors
7.2.6.2. Restraining factors
7.2.7. Regulatory issues, legislations and authorities
7.2.8. Insurance reimbursement scenario
7.2.9. Company profiles
7.2.9.1. IVI Panama
7.2.9.1.1. Company overview
7.2.9.2. IVF Panama Center for Reproduction Punta Pacfica
7.2.9.2.1. Company overview
7.2.9.3. The Hugh Wynter Fertility Management Unit
7.2.9.3.1. Company overview
7.3. Middle East IVF Services Market, (Revenue and Number of Cycles)
7.3.1. Overview
7.3.2. Market size and forecast
7.3.3. IVF clinics in Middle East
7.3.4. Middle East IVF services market, by end user
7.3.4.1. Market size and forecast
7.3.4.2. Market volume and forecast
7.3.4.3. Fertility clinics
7.3.4.4. Hospitals
7.3.4.5. Surgical centers
7.3.4.6. Clinical research institutes
7.3.5. Middle East IVF services market, by cycle type
7.3.5.1. Market size and forecast
7.3.5.2. Market volume and forecast
7.3.5.3. Fresh IVF cycles (non-donor)
7.3.5.4. Thawed IVF cycles (non-donor)
7.3.5.5. Donor egg IVF cycles
7.3.6. Market dynamics
7.3.6.1. Driving factors
7.3.6.2. Restraining factors
7.3.7. Regulatory issues, legislations and authorities
7.3.8. Insurance reimbursement scenario
7.3.9. Company profiles
7.3.9.1. Cyprus IVF Centre
7.3.9.1.1. Company overview
7.3.9.2. Bourn Hall International
7.3.9.2.1. Company overview
7.3.9.3. Fakih IVF Fertility Center
7.3.9.3.1. Company overview
7.4. Africa IVF Services Market, (Revenue and Number of Cycles)
7.4.1. Overview
7.4.2. Market size and forecast
7.4.3. IVF clinics in Africa
7.4.4. Africa IVF services market, by end user
7.4.4.1. Market size and forecast
7.4.4.2. Market volume and forecast
7.4.4.3. Fertility clinics
7.4.4.4. Hospitals
7.4.4.5. Surgical centers
7.4.4.6. Clinical research institutes
7.4.5. Africa IVF services market, by cycle type
7.4.5.1. Market size and forecast
7.4.5.2. Market volume and forecast
7.4.5.3. Fresh IVF cycles (non-donor)
7.4.5.4. Thawed IVF cycles (non-donor)
7.4.5.5. Donor egg IVF cycles
7.4.6. Market dynamics
7.4.6.1. Driving factors
7.4.6.2. Restraining factors
7.4.7. Regulatory issues, legislations and authorities
7.4.8. Insurance reimbursement scenario
7.4.9. Company profiles
7.4.9.1. Medfem Fertility Clinic
7.4.9.1.1. Company overview
7.4.9.2. The Cape Fertility Clinic
7.4.9.2.1. Company overview
7.4.9.3. Lifesure Fertility and Gynaecology Centre
7.4.9.3.1. Company overview

List of Tables
TABLE 01. IVF PRICING TRENDS, BY COUNTRY, 2017
TABLE 02. GLOBAL IVF MARKET, BY COUNTRY, 2016-2023 (THOUSAND)
TABLE 03. GLOBAL IVF SERVICES MARKET REVENUE, BY END USER, 2017-2025 ($MILLION)
TABLE 04. GLOBAL IVF SERVICES MARKET VOLUME, BY END USER, 2017-2025 (THOUSAND)
TABLE 05. GLOBAL IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2017-2025 ($MILLION)
TABLE 06. GLOBAL IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2017-2025 (THOUSAND)
TABLE 07. INFERTILITY PROBLEM IN THE U.S.
TABLE 08. GLOBAL DISPOSABLE INCOME, 20172024
TABLE 09. NORTH AMERICA IVF SERVICES MARKET REVENUE, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 10. NORTH AMERICA IVF SERVICES MARKET REVENUE, BY END USER, 2017-2025 ($MILLION)
TABLE 11. NORTH AMERICA IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2017-2025 ($MILLION)
TABLE 12. NORTH AMERICA IVF SERVICES MARKET VOLUME, BY COUNTRY, 2017-2025 (THOUSAND)
TABLE 13. NORTH AMERICA IVF SERVICES MARKET VOLUME, BY END USER, 2017-2025 (THOUSAND)
TABLE 14. NORTH AMERICA IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2017-2025 (THOUSAND)
TABLE 15. IVF SUCCESS RATES FOR FRESH EMBRYOS FROM NONDONOR EGGS, U.S., 2015
TABLE 16. IVF SUCCESS RATES FOR FROZEN EMBRYOS FROM NONDONOR EGGS, U.S., 2015
TABLE 17. IVF SUCCESS RATES FOR DONOR EGGS, U.S., 2015
TABLE 18. LIST OF FEW IVF CLINICS IN THE U.S.
TABLE 19. U.S. IVF SERVICES MARKET REVENUE, BY END USER, 2017-2025 ($MILLION)
TABLE 20. U.S. IVF SERVICES MARKET VOLUME, BY END USER, 2017-2025 (THOUSAND)
TABLE 21. U.S. IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2017-2025 ($MILLION)
TABLE 22. U.S. IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2017-2025 (THOUSAND)
TABLE 23. LAWS RELATED TO INSURANCE COVERAGE FOR INFERTILITY TREATMENTS IN U.S.
TABLE 24. FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF BUSINESS OVERVIEW
TABLE 25. SNAPSHOT OF FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY
TABLE 26. CONCEPTIONS REPRODUCTIVE ASSOCIATES BUSINESS OVERVIEW
TABLE 27. SNAPSHOT OF CONCEPTIONS REPRODUCTIVE ASSOCIATES
TABLE 28. SERVY MASSEY FERTILITY INSTITUTE BUSINESS OVERVIEW
TABLE 29. SNAPSHOT OF SERVY MASSEY FERTILITY INSTITUTE
TABLE 30. SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM) BUSINESS OVERVIEW
TABLE 31. SNAPSHOT OF SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)
TABLE 32. CARDONE REPRODUCTIVE MEDICINE AND INFERTILITY, LLC BUSINESS OVERVIEW
TABLE 33. SNAPSHOT OF CARDONE REPRODUCTIVE MEDICINE AND INFERTILITY, LLC
TABLE 34. FERTILITY CENTER OF SAN ANTONI BUSINESS OVERVIEW
TABLE 35. SNAPSHOT OF FERTILITY CENTER OF SAN ANTONI
TABLE 36. HOUSTON FERTILITY CENTER BUSINESS OVERVIEW
TABLE 37. SNAPSHOT OF HOUSTON FERTILITY CENTER
TABLE 38. NEW HOPE FERTILITY CENTER BUSINESS OVERVIEW
TABLE 39. SNAPSHOT OF NEW HOPE FERTILITY CENTER
TABLE 40. LIST OF FEW IVF CLINICS IN CANADA
TABLE 41. CANADA IVF SERVICES MARKET REVENUE, BY END USER, 2017-2025 ($MILLION)
TABLE 42. CANADA IVF SERVICES MARKET VOLUME, BY END USER, 2017-2025 (THOUSAND)
TABLE 43. CANADA IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2017-2025 ($MILLION)
TABLE 44. CANADA IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2017-2025 (THOUSAND)
TABLE 45. TREATMENT TYPES AND COVERAGE LIMITS IN ONTARIO, CANADA
TABLE 46. TRIO FERTILITY BUSINESS OVERVIEW
TABLE 47. SNAPSHOT OF TRIO FERTILITY
TABLE 48. THE MONTREAL FERTILITY CENTER BUSINESS OVERVIEW
TABLE 49. SNAPSHOT OF THE MONTREAL FERTILITY CENTER
TABLE 50. PROCREA FERTILITY BUSINESS OVERVIEW
TABLE 51. SNAPSHOT OF PROCREA FERTILITY
TABLE 52. IVF CANADA OVERVIEW
TABLE 53. SNAPSHOT OF IVF CANADA
TABLE 54. LIST OF A FEW FERTILITY CLINICS IN MEXICO
TABLE 55. MEXICO IVF SERVICES MARKET REVENUE, BY END USER, 2017-2025 ($MILLION)
TABLE 56. MEXICO IVF SERVICES MARKET VOLUME, BY END USER, 2017-2025 (THOUSAND)
TABLE 57. MEXICO IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2017-2025 ($MILLION)
TABLE 58. MEXICO IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2017-2025 (THOUSAND)
TABLE 59. LIV FERTILITY CENTER BUSINESS OVERVIEW
TABLE 60. SNAPSHOT OF LIV FERTILITY CENTER
TABLE 61. BIOFERTILITY CENTER BUSINESS OVERVIEW
TABLE 62. SNAPSHOT OF BIOFERTILITY CENTER
TABLE 63. IVINSEMER BUSINESS OVERVIEW
TABLE 64. SNAPSHOT OF IVINSEMER
TABLE 65. EUROPE IVF SERVICES MARKET REVENUE, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 66. EUROPE IVF SERVICES MARKET REVENUE, BY END USER, 2017-2025 ($MILLION)
TABLE 67. EUROPE IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2017-2025 ($MILLION)
TABLE 68. EUROPE IVF SERVICES MARKET VOLUME, BY COUNTRY, 2017-2025 (THOUSAND)
TABLE 69. EUROPE IVF SERVICES MARKET VOLUME, BY END USER, 2017-2025 (THOUSAND)
TABLE 70. EUROPE IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2017-2025 (THOUSAND)
TABLE 71. NUMBER OF CYCLES, GERMANY, 2015
TABLE 72. LIST OF A FEW FERTILITY CLINICS IN GERMANY
TABLE 73. GERMANY IVF SERVICES MARKET REVENUE, BY END USER, 2017-2025 ($MILLION)
TABLE 74. GERMANY IVF SERVICES MARKET VOLUME, BY END USER, 2017-2025 (THOUSAND)
TABLE 75. GERMANY IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2017-2025 ($MILLION)
TABLE 76. GERMANY IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2017-2025 (THOUSAND)
TABLE 77. HEIDELBERG UNIVERSITY HOSPITAL BUSINESS OVERVIEW
TABLE 78. SNAPSHOT OF HEIDELBERG UNIVERSITY HOSPITAL
TABLE 79. WUNSCHKINDER BUSINESS OVERVIEW
TABLE 80. SNAPSHOT OF WUNSCHKINDER
TABLE 81. FERTILITY CENTER BERLIN BUSINESS OVERVIEW
TABLE 82. SNAPSHOT OF FERTILITY CENTER BERLIN
TABLE 83. AMEDES MVZ COLOGNE GMBH BUSINESS OVERVIEW
TABLE 84. SNAPSHOT OF AMEDES MVZ COLOGNE GMBH
TABLE 85. LIST OF FEW IVF CLINICS IN FRANCE
TABLE 86. FRANCE IVF SERVICES MARKET REVENUE, BY END USER, 2017-2025 ($MILLION)
TABLE 87. FRANCE IVF SERVICES MARKET VOLUME, BY END USER, 2017-2025 (THOUSAND)
TABLE 88. FRANCE IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2017-2025 ($MILLION)
TABLE 89. FRANCE IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2017-2025 (THOUSAND)
TABLE 90. AMBROISE PAR GROUP BUSINESS OVERVIEW
TABLE 91. SNAPSHOT OF AMBROISE PAR GROUP

Please contact our Customer Support Center to get the complete Table of Contents

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.